496 related articles for article (PubMed ID: 19574223)
1. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells.
Guttilla IK; White BA
J Biol Chem; 2009 Aug; 284(35):23204-16. PubMed ID: 19574223
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of MircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1.
Wu Z; Sun H; Zeng W; He J; Mao X
PLoS One; 2012; 7(9):e45825. PubMed ID: 23029264
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-96 promotes the proliferation of colorectal cancer cells and targets tumor protein p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1) and FOXO3a.
Gao F; Wang W
Mol Med Rep; 2015 Feb; 11(2):1200-6. PubMed ID: 25369914
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.
Xu Y; Zhao S; Cui M; Wang Q
Int J Clin Exp Pathol; 2015; 8(9):10294-304. PubMed ID: 26617737
[TBL] [Abstract][Full Text] [Related]
5. MiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1.
Zhang LY; Chen Y; Jia J; Zhu X; He Y; Wu LM
Cancer Biomark; 2019; 24(1):31-42. PubMed ID: 30614794
[TBL] [Abstract][Full Text] [Related]
6. Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer.
Myatt SS; Wang J; Monteiro LJ; Christian M; Ho KK; Fusi L; Dina RE; Brosens JJ; Ghaem-Maghami S; Lam EW
Cancer Res; 2010 Jan; 70(1):367-77. PubMed ID: 20028871
[TBL] [Abstract][Full Text] [Related]
7. miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.
Li W; Yi J; Zheng X; Liu S; Fu W; Ren L; Li L; Hoon DSB; Wang J; Du G
Clin Epigenetics; 2018; 10():64. PubMed ID: 29796115
[TBL] [Abstract][Full Text] [Related]
8. The antiapoptotic function of miR-96 in prostate cancer by inhibition of FOXO1.
Fendler A; Jung M; Stephan C; Erbersdobler A; Jung K; Yousef GM
PLoS One; 2013; 8(11):e80807. PubMed ID: 24260486
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1.
Liu DZ; Chang B; Li XD; Zhang QH; Zou YH
Clin Transl Oncol; 2017 Sep; 19(9):1133-1140. PubMed ID: 28397066
[TBL] [Abstract][Full Text] [Related]
10. [MiR-135b promotes proliferation of endometrial carcinoma cells by targeting FOXO1].
Yue Z; Shen JJ; Huang QT; Qin YF; Li XN; Liu GB
Nan Fang Yi Ke Da Xue Xue Bao; 2016 May; 36(5):675-80. PubMed ID: 27222184
[TBL] [Abstract][Full Text] [Related]
11. Leucine promotes porcine myofibre type transformation from fast-twitch to slow-twitch through the protein kinase B (Akt)/forkhead box 1 signalling pathway and microRNA-27a.
Zhang S; Chen X; Huang Z; Chen D; Yu B; Chen H; He J; Luo J; Zheng P; Yu J; Luo Y
Br J Nutr; 2019 Jan; 121(1):1-8. PubMed ID: 30449288
[TBL] [Abstract][Full Text] [Related]
12. FOXO1 3'UTR functions as a ceRNA in repressing the metastases of breast cancer cells via regulating miRNA activity.
Yang J; Li T; Gao C; Lv X; Liu K; Song H; Xing Y; Xi T
FEBS Lett; 2014 Aug; 588(17):3218-24. PubMed ID: 25017439
[TBL] [Abstract][Full Text] [Related]
13. Human-specific microRNA regulation of FOXO1: implications for microRNA recognition element evolution.
McLoughlin HS; Wan J; Spengler RM; Xing Y; Davidson BL
Hum Mol Genet; 2014 May; 23(10):2593-603. PubMed ID: 24368418
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of miR-370 contributes to the progression of gastric carcinoma via suppression of FOXO1.
Fan C; Liu S; Zhao Y; Han Y; Yang L; Tao G; Li Q; Zhang L
Biomed Pharmacother; 2013 Jul; 67(6):521-6. PubMed ID: 23721824
[TBL] [Abstract][Full Text] [Related]
15. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic miR-9 is a target of erlotinib in NSCLCs.
Chen X; Zhu L; Ma Z; Sun G; Luo X; Li M; Zhai S; Li P; Wang X
Sci Rep; 2015 Nov; 5():17031. PubMed ID: 26593208
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of miR-96 enhances cellular proliferation of prostate cancer cells through FOXO1.
Haflidadóttir BS; Larne O; Martin M; Persson M; Edsjö A; Bjartell A; Ceder Y
PLoS One; 2013; 8(8):e72400. PubMed ID: 23951320
[TBL] [Abstract][Full Text] [Related]
18. miR-96 promotes cell proliferation and clonogenicity by down-regulating of FOXO1 in prostate cancer cells.
Yu JJ; Wu YX; Zhao FJ; Xia SJ
Med Oncol; 2014 Apr; 31(4):910. PubMed ID: 24633705
[TBL] [Abstract][Full Text] [Related]
19. miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1.
Kim KM; Park SJ; Jung SH; Kim EJ; Jogeswar G; Ajita J; Rhee Y; Kim CH; Lim SK
J Bone Miner Res; 2012 Aug; 27(8):1669-79. PubMed ID: 22431396
[TBL] [Abstract][Full Text] [Related]
20. Modulation of FoxO1 expression by miR-21 to promote growth of pancreatic ductal adenocarcinoma.
Song W; Li Q; Wang L; Wang L
Cell Physiol Biochem; 2015; 35(1):184-90. PubMed ID: 25591761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
